Smith Jason Drew - Insider Non-Derivative Transactions at UroGen Pharma Ltd. (URGN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 9, 2024, Smith Jason Drew's relationship to UroGen Pharma Ltd. (URGN) is Officer (General Counsel), and currently has 26,747 shares of Ordinary Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other URGN insiders.
Data Source: SEC.
Smith Jason Drew - Insider Non-Derivative Transactions of URGN Ordinary Shares
Smith Jason Drew - Insider Non-Derivative Transactions at URGN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 10, 2024 | Sell -- (Ordinary Shares) | 1521 | 13.08 | 25226 |
| Sep 10, 2024 | M -- (Ordinary Shares) | 3333 | 0 | 26747 |
| Feb 2, 2024 | Sell -- (Ordinary Shares) | 417 | 15.78 | 18824 |
| Feb 2, 2024 | Sell -- (Ordinary Shares) | 1248 | 15.78 | 20076 |
| Feb 2, 2024 | Sell -- (Ordinary Shares) | 3328 | 15.78 | 23414 |
| Feb 1, 2024 | Sell -- (Ordinary Shares) | 417 | 15.74 | 18824 |
| Feb 1, 2024 | M -- (Ordinary Shares) | 834 | 0 | 19241 |
| Feb 1, 2024 | Sell -- (Ordinary Shares) | 1248 | 15.74 | 20076 |
| Feb 1, 2024 | M -- (Ordinary Shares) | 2500 | 0 | 21324 |
| Feb 1, 2024 | Sell -- (Ordinary Shares) | 3328 | 15.74 | 23414 |
| Feb 1, 2024 | M -- (Ordinary Shares) | 6666 | 0 | 26742 |
| Sep 1, 2023 | Sell -- (Ordinary Shares) | 3800 | 18.01 | 18407 |
| Sep 1, 2023 | M -- (Ordinary Shares) | 8334 | 0 | 22207 |
| Feb 1, 2023 | Sell -- (Ordinary Shares) | 409 | 10.12 | 12600 |
| Feb 1, 2023 | M -- (Ordinary Shares) | 833 | 0 | 13009 |
| Feb 1, 2023 | Sell -- (Ordinary Shares) | 1227 | 10.12 | 13873 |
| Feb 1, 2023 | M -- (Ordinary Shares) | 2500 | 0 | 15100 |